Literature DB >> 20806854

[Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray].

Ping Wang1, Tao Fu, Xurui Wang, Wei Zhu.   

Abstract

OBJECTIVE: To detect the expression of microRNAs (miRNAs) in laryngeal carcinoma and adjacent normal tissue using microarray, and to discuss the relationship between miRNAs and laryngeal carcinoma.
METHOD: miRNA were extracted from 8 cases of laryngeal cancer tissue and its adjacent normal tissue. miRNA identification were performed by microarray of miRNA hybridization and cluster analysis was used with Significance Analysis of Microarrays (SAM, version 2.1) and Cluster 3.0 software. miRNA were confirmed by real time quantification RT-PCR with RNA-tailing and primer extension. RESULT: Totally 47 different miRNAs were found expressed in laryngeal cancer, with 23 of miRNA expression were up-regulated and 24 of miRNA expression were down-regulated. The expression of miR-1, miR-486-5p, miR-206, miR-487a,miR-375, miR-422a, miR-144, miR-384, miR-378, miR-133a were down-regulated by 5 multiple and while expression of miR-93, miR-31, miR-20b were up-regulated by 3 multiple. There are 5 miRNA clusters with coexpression in laryngeal cancer tissue and located on chromosome 8, 13, 14, 18 and X. Moreover, RT-PCR analysis demonstrated that there was no significantly difference of miRNA expression between microarray and RT-PCR.
CONCLUSION: The different expression of miRNA may play an important role in the pathogenesis and development of laryngeal cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20806854

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  14 in total

1.  MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47.

Authors:  Hui Li; Yan Wang; Yan-Zhong Li
Journal:  Tumour Biol       Date:  2016-10-11

2.  MicroRNA differential expression spectrum and microRNA-125a-5p inhibition of laryngeal cancer cell proliferation.

Authors:  Xiang-Dong Yao; Ping Li; Ji-Sheng Wang
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

3.  miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression.

Authors:  Yuan-Fei Ren; Tie-Hui Zhang; Sheng Zhong; Yan-Tao Zhao; Ya-Nan Lv
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

4.  CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

Authors:  Jian Zheng; Xiaobai Liu; Ping Wang; Yixue Xue; Jun Ma; Chengbin Qu; Yunhui Liu
Journal:  Mol Ther       Date:  2016-04-08       Impact factor: 11.454

5.  Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Authors:  Martina Redova; Alexandr Poprach; Jana Nekvindova; Robert Iliev; Lenka Radova; Radek Lakomy; Marek Svoboda; Rostislav Vyzula; Ondrej Slaby
Journal:  J Transl Med       Date:  2012-03-22       Impact factor: 5.531

6.  Epigenetic dysregulation in laryngeal squamous cell carcinoma.

Authors:  Thian-Sze Wong; Wei Gao; Zeng-Hong Li; Jimmy Yu-Wai Chan; Wai-Kuen Ho
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

7.  A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.

Authors:  Jiaze An; Jibin Liu; Li Liu; Yao Liu; Yun Pan; Mingde Huang; Fuzhen Qi; Juan Wen; Kaipeng Xie; Hongxia Ma; Hongbing Shen; Zhibin Hu
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

8.  Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma.

Authors:  Zhong-Ming Lu; Ye-Feng Lin; Li Jiang; Liang-Si Chen; Xiao-Ning Luo; Xin-Han Song; Shao-Hua Chen; Si-Yi Zhang
Journal:  Onco Targets Ther       Date:  2014-04-05       Impact factor: 4.147

9.  MiRNAs which target CD3 subunits could be potential biomarkers for cancers.

Authors:  Fariborz Asghari Alashti; Zarrin Minuchehr
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis.

Authors:  Zheng Cao; Benjamin T Moore; Yang Wang; Xian-Hao Peng; Joan M Lappe; Robert R Recker; Peng Xiao
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.